← Back to Search

Remote Monitoring and Social Intervention for High Blood Pressure (E3 Trial)

N/A
Recruiting
Led By David A Ansell, MD, MPH
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Stage II hypertension (140/90) or greater
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-6 month follow-up after the 12 week intervention
Awards & highlights

E3 Trial Summary

This trial seeks to reduce unequal high BP rates between African American & Latinx patients in Rush University Medical Center clinics.

Who is the study for?
This trial is for African American and Latinx individuals with Stage II high blood pressure (140/90 or higher) who are patients at eligible Rush University Medical Center clinics. Participants must have access to a phone or device with video capabilities.Check my eligibility
What is being tested?
The study tests the 'E3 Remote Monitoring and Social Intervention' program, aiming to reduce racial disparities in managing high blood pressure among African American and Latinx communities.See study design
What are the potential side effects?
Since this trial involves remote monitoring and social interventions rather than medication, traditional side effects are not applicable. However, participants may experience privacy concerns or stress related to constant health monitoring.

E3 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My blood pressure is 140/90 or higher.

E3 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-6 month follow-up after the 12 week intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-6 month follow-up after the 12 week intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of total participants with improvement of hypertension to below 130/80 mmHg and/or a decrease of 10mmHg in systolic readings
Percentage of total participants with sustained improvement of blood pressure below 130/80 mmHg at 3-6 month follow-up
Secondary outcome measures
Correlation of change in SDOH survey score in relation to hypertension control below 130/80 mmHg
Correlation of frequency of self monitoring with post intervention ARMS survey scores
Correlation of initial SDOH survey score in relation to hypertension control below 130/80 mmHg

E3 Trial Design

1Treatment groups
Experimental Treatment
Group I: Remote Blood Pressure Monitoring and Social InterventionExperimental Treatment1 Intervention
Participants are enrolled in a remote blood pressure monitoring program and social intervention composed of remote outreach from a team of community health worker, pharmacist, nurse, and social worker for 12 weeks.

Find a Location

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
422 Previous Clinical Trials
162,301 Total Patients Enrolled
Novartis PharmaceuticalsIndustry Sponsor
2,859 Previous Clinical Trials
4,197,044 Total Patients Enrolled
David A Ansell, MD, MPHPrincipal InvestigatorRush University Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are currently participating in this clinical trial?

"Affirmative. The records on clinicaltrials.gov verify that this medical experiment, first announced on September 13th 2023 is currently recruiting patients. A total of 1200 participants are required from a single centre."

Answered by AI

Is it still feasible to join this medical experiment?

"That is correct. As per the information posted on clinicaltrials.gov, this medical study opened recruitment on September 13th 2023 and was recently updated on September 18th of that same year. In total 1 facility needs to enroll 1200 participants."

Answered by AI

Who else is applying?

What site did they apply to?
Rush University Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+
Recent research and studies
clinicaltrials.govStudy
Novartis - Closing the Gap in Cardiovascular Risk: Engage, Empower, Evaluate
2023. "Novartis - Closing the Gap in Cardiovascular Risk: Engage, Empower, Evaluate". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06027905.
All > High Blood Pressure
~640 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top